ENSG
Ensign Group Inc/The
NASDAQ · Health Care
$197.80
+0.64 (+0.32%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 4.25B | 3.62B | 4.26B | 4.21B | 4.15B |
| Net Income | 297.32M | 227.78M | 488.28M | 452.95M | 453.91M |
| EPS | — | — | — | — | — |
| Profit Margin | 7.0% | 6.6% | 11.5% | 10.8% | 11.0% |
| Rev Growth | +17.5% | +17.5% | -2.0% | +1.5% | -7.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 422.28M | 422.28M | 3.73B | 3.37B | 3.51B |
| Total Equity | 5.33B | 5.33B | 4.76B | 4.63B | 4.21B |
| D/E Ratio | 0.08 | 0.08 | 0.78 | 0.73 | 0.83 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 448.79M | 362.91M | 789.85M | 812.11M | 863.45M |
| Free Cash Flow | — | — | 514.09M | 544.25M | 422.07M |